Regulators in Brazil have approved a health claim for leading probiotic GanedenBC30, creating new opportunities to meet growing demand for products with digestive health benefits.
As a result of recent regulatory work, Ganeden has made advancements for the usage of its patented and shelf-stable probiotic strain, GanedenBC30 (Bacillus coagulans GBI-30 6086), in Canada.